Latest filing published 21 Dec 2015 for ZS Pharma, Inc., €1.3M.
No signal scores available.
All filings by Alvaro Guillem on record concern ZS Pharma, Inc. Between 23 June 2014 and 17 December 2015, the trades on record add up to 4 filings.
None of the filings is a plain purchase or sale on the open market; they cover grants, option exercises and other movements. Because grants and exercises are largely decided by remuneration plans, they are not counted as purchases here.
Most recently, on 21 December 2015, the filings show a transaction worth €1.3M in ZS Pharma, Inc. Typically, a trade is published a median of 3 days after it takes place. Section 16 rules allow two business days to file each Form 4. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
4 of 4 declarations